UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055146 |
|---|---|
| Receipt number | R000063001 |
| Scientific Title | Clinical usefulness evaluation of beta-glucan measurement reagent beta-glucan Single M30 Test Wako |
| Date of disclosure of the study information | 2024/09/01 |
| Last modified on | 2024/08/02 15:55:52 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinical usefulness evaluation of fungal infection measurement reagents
Acronym
Clinical usefulness evaluation of fungal infection measurement reagents
Scientific Title
Clinical usefulness evaluation of beta-glucan measurement reagent beta-glucan Single M30 Test Wako
Scientific Title:Acronym
Clinical usefulness evaluation of beta-glucan measurement reagent beta-glucan Single M30 Test Wako
Region
| Japan |
Condition
Condition
fungal infection
Classification by specialty
| Laboratory medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Performance evaluation of new reagent beta-glucan M30 single test Wako
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Confirmation of simultaneous reproducibility with serum samples and correlation with plasma samples
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Targeted at patients attending or being hospitalized at Juntendo Urayasu Hospital, Juntendo University School of Medicine.
Key exclusion criteria
Patients judged by the research director to be unsuitable as subjects
Target sample size
180
Research contact person
Name of lead principal investigator
| 1st name | Tomohiko |
| Middle name | |
| Last name | Ai |
Organization
Juntendo University Urayasu Hospital
Division name
Clinical Laboratory Medicine
Zip code
270-0021
Address
2-1-1 Tomioka,Urayasu,Chiba
TEL
047-353-3111
t-ai@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Yasuyo |
| Middle name | |
| Last name | Ode |
Organization
Juntendo University Urayasu Hospital
Division name
Clinical Laboratory Medicine
Zip code
270-0021
Address
2-1-1 Tomioka,Urayasu,Chiba
TEL
047-353-3111
Homepage URL
y.ode.de@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University
Institute
Department
Personal name
Funding Source
Organization
Fujifilm Wako Pure Chemical Industries, Ltd.
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Juntendo University Urayasu Hospital
Address
2-1-1 Tomioka,Urayasu,Chiba
Tel
047-353-3111
y.ode.de@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 09 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2024 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 09 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
No special notes
Management information
Registered date
| 2024 | Year | 08 | Month | 02 | Day |
Last modified on
| 2024 | Year | 08 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063001
